Kerstin Noëlle Vokinger explains in an article in swissinfo how drug prices are regulated in Switzerland and why drug prices in Europe can't just rise at the flip of a switch.
More money is spent on cancer in Switzerland per capita than any other country in Europe, but this doesn’t translate to higher survival rates. Kerstin Noëlle Vokinger talks to swissinfo about possible reasons.